Overview

Resveratrol as a Preventive Treatment of OHSS

Status:
Completed
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of resveratrol treatment oh ovarian hyperstimulation syndrome in egg donors
Phase:
Phase 3
Details
Lead Sponsor:
IVI Madrid
Treatments:
Resveratrol